Retigabine
SIAL/90221 - analytical standard
Synonym: D-23129; Ezogabine; N-
CAS Number: 150812-12-7
Empirical Formula (Hill Notation): C16H18FN3O2
Molecular Weight: 303.33
MDL Number: MFCD04307735
Linear Formula: C16H18FN3O2
Product Type: Chemical
| application(s) | forensics and toxicology veterinary |
| assay | ≥98.0% (HPLC) |
| drug control | USDEA Schedule IV |
| format | neat |
| grade | analytical standard |
| impurities | ≤1.0% water (calc. from elemental analysis) |
| InChI | 1S/C16H18FN3O2/c1-2-22-16 |
| InChI key | PCOBBVZJEWWZFR-UHFFFAOYSA |
| Quality Level | 100 ![]() |
| shelf life | limited shelf life, expiry date on the label |
| SMILES string | FC1=CC=C(CNC2=CC(N)=C(NC( |
| storage temp. | 2-8°C |
| technique(s) | gas chromatography (GC): suitable |
| HPLC: suitable |
| Application: | Retigabine may be used as a reference standard in the determination of retigabine in biological matrices using high-performance liquid chromatography coupled with tandem mass spectrometry with positive ion atmospheric pressure chemical ionization (HPLC-APCI-MS/MS). |
| Biochem/physiol Actions: | Retigabine (Ezogabine) is a Kv7.2-7.5 (KCNQ2-5) neuronal potassium channel opener witrh anticonvulsant activity. |
| Biochem/physiol Actions: | Retigabine is a Kv7.2-7.5 potassium channel activator; anticonvulsant. |
| General description: | Retigabine is an antiepileptic drug, which activates neuronal KCNQ-type K+ channels by inducing a large hyperpolarizing shift of steady-state activation. |
| Symbol | ![]() GHS06,GHS09 |
| Signal word | Danger |
| Hazard statements | H301 + H331 - H410 |
| Precautionary statements | P261 - P264 - P270 - P273 - P301 + P310 - P304 + P340 + P311 |
| Hazard Codes | Xi |
| Risk Statements | 36 |
| Safety Statements | 26 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98.0% (HPLC) |
| Storage Temp. | 2-8°C |
| UNSPSC | 41116107 |



